Select Page
Applications » ROXY Reactors » Disulfide bond reduction

Disulfide bond reduction

ROXY Reactors for disulfide bond reduction

The ROXY Exceed with an EC Reactor has been developed for fast and efficient reduction of disulfide bonds in proteins. The reduction of intra- and intermolecular disulfide bonds is a small but crucial step in the workflow for successful structure elucidation and assignment of the bonding sites by MS. The method is based on an electric potential to trigger the reduction reaction, no reductive chemicals are used.

Traditionally, reduction is performed using concentrated chemicals, e.g. dithiothreitol (DTT) that needs to be removed prior LC/MS analysis. Alternatively, thiol – free reducing agents such as TCEP (tris (2-carboxyethyl) phosphine) can be used. However, sample preparation remains laborious and difficult to combine with on-line LC/MS. Electrochemistry in an on-line setup with MS is clean, no chemicals are needed and the result can be monitored instantaneously.

For more details: see our technology page.

Breaking of a disulfide bond in an electrochemical flow-through reactor requires a potential of about -1 V.

Insulin

Insulin, a small protein of 5733 Da is used as model compound for the S-S reduction. It consists of 51 amino acids forming two chains, A and B, and contains 3 disulfide bonds. Two interchain S-S bonds connecting chain A and B and one intrachain S-S bond located on chain A. The disulfide bonds can be completely reduced using an electrochemical reactor.

Almost complete reduction of all three S-S bonds in Insulin was obtained using the ROXY EC system up-front MS.

Application notes

 

Rev
Name
Size
Download
210_003_01
Superior Characterization of Protein Therapeutics
1.12 MB
210_006_05
Reduction of Disulfide Bonds in Proteins
0.83 MB
210_008_04
Reduction and Engineering of mAbs
0.69 MB
210_009_06
Electrochemical Reduction of Biopharmaceuticals in HDX-MS
2.43 MB
210_010_04
Monitoring Electrochemical Reduction
1.00 MB
210_013_02
Superior Reduction of Disulfide Bonds in HDXMS
1.37 MB
210_014_02
Metabolism of 3 New Cardiovascular Drugs
1.20 MB
210_015_02
Electrochemical Reduction of Biopharmaceuticals
0.81 MB
210_000_01
Antibody subunit analysis via EC Reduction
0.67 MB
210_000_02
Improved and universal inline electrochemical reduction of mAbs
2.05 MB

Posters

 

Rev
Name
Size
Download
221_241_01
Reduction (Insuline, Avastin Fab)
1.67 MB
221_244_01
New EC cell for reduction of protein disulfide bonds in HDX─MS (Insuline, NGF, VEGF)
5.42 MB
221_248_02
EC Reduction of Disulfide Bonds in Proteins & Biopharmaceuticals (Insulin, Avastin Fab, NGF, VEGF)
4.88 MB